DE
BioCopy-Keyimage-09-News-02.jpg

From the scientist's bench

Press Releases, News, Events

Welcome to the BioCopy newsroom

June 7th, 2022
Vaccine development against ASF
Essential data for vaccine development against African swine fever (ASF)
Read more
March 29th, 2022
BioCopy AG presents ValidaTe
A novel ultra-fast screening technology to significantly speed up drug discovery in T-cell therapy
Read more
February 10th, 2022
Let's connect at Bio-Europe Spring
BioCopy will be partnering at Bio-Europe Spring, March 28-31, 2022.  We are showcasing our unique technology for vaccine development and immunotherapy.
Read more
February 9th, 2022
BioCopy now a registered US trademark
This will strengthen our company’s prospects for the world's largest markets of biomedical innovation.
Read more
October 1st, 2021
Quick and easy determination of personal immune status against Covid-19
New biosensor developed by BioCopy and Freiburg University Clinic
July 7th, 2021
BioCopy AG and Immatics enter into collaboration
Characterization of T-cell receptor – peptide-HLA interactions
May 27th, 2021
Collaboration with Valneva
BioCopy technology enables further development of vaccines with regard to their effectiveness on a large number of variants.
March 30th, 2021
Working on a vaccine against African swine fever
BioCopy Holding AG and Institute of Virology and Immunology (IVI) announce collaboration on African swine fever